Transforming growth factor /61 81) decreased the rate of proliferation of rat aortic vascular smooth muscle cells (VSMCs) stimulated with serum showing a maximal effect at > 5 ng/ml (200 pM). However, it did not reduce the proportion of cells which passed through S phase (> 90%) and entry into S phase was delayed by less than 3 h. The proportion of cells passing through M phase (> 90%) was also unaffected, but entry into mitosis was delayed by approx. 24 h. This increase in cell cycle time was therefore due mainly to an increase in the G2 to mitotic metaphase period. Addition of TGF-f81 late in G1 or late in S phase failed to delay the onset of mitosis, but the presence of TGF-,81 between 0 and 12 h after the addition of serum to quiescent cells was sufficient to cause the maximal delay in mitosis of approx. 24 h. The role ofcyclic AMP in the mechanism of the TGF-,81 effects on the cell cycle was examined. Entry into mitosis was preceded by a transient 2-fold increase in cyclic AMP concentration and TGF-,/1 delayed both this increase in cyclic AMP and entry into mitosis to the same extent. Addition of
INTRODUCTION
The proliferation of intimal vascular smooth muscle cells (VSMCs) in vascular disease is considered to result from endothelial dysfunction or injury [1, 2] . One consequence of the absence of a functional endothelium is increased adhesion of leucocytes and platelets at the site of injury [3] . The VSMCs migrate to form a neointima in response to release by platelets of chemotactic substances, in particular platelet-derived growth factor (PDGF) [4] . These intimal VSMCs proliferate in response to a complex mixture of growth-promoting substances released by adherent leucocytes, macrophages, platelets [5] [6] [7] , endothelial cells [8] and by the intimal VSMCs themselves [9, 10] . The establishment of a neointima is assumed to depend on the balance between growth-promoting agents and factors which inhibit the de-differentiation, migration and/or proliferation of the medial VSMCs. One such potential growth-industry substance is transforming growth factor (TGF-,5) [11] [12] [13] .
The TGF-,8 isoforms are a family of multifunctional dimeric polypeptides which are known to have diverse roles, affecting proliferation and differentiation of various cell types ( [14] [15] [16] [17] and reviewed in [18] ). The best-studied member of the family, TGF-/51, is a disulphide-linked dimer of two identical chains of 112 amino acids and is contained in the alpha granules of forskolin or 8-(4-chlorophenylthio)-cyclic AMP to cells 30 h after stimulation with serum completely reversed the increase in duration of G2 in the presence of TGF-fil, suggesting that the rise in cyclic AMP levels which precedes mitosis might trigger entry of the VSMCs into M phase. Addition of forskolin late in S phase (26 h after stimulation with serum) advanced the entry of the cells into M phase and they divided prematurely. This effect was unaffected by the addition of cycloheximide with the forskolin; however, the effect of forskolin on cell division was completely inhibited when cycloheximide was added late in G1.
TGF-f1 prevented the loss of smooth-muscle-specific myosin heavy chain (SM-MHC), which occurs in primary VSMC cultures in the presence or absence of serum, and the cells proliferated while maintaining a differentiated phenotype. However, TGF-fll did not cause re-differentiation of subcultured VSMCs which contained very low amounts of SM-MHC and the effect of TGF-,81 in extending the G2 phase of the cell cycle is exerted independently of its effect on differentiation.
platelets [19] . It is released in a latent form from platelets at sites of injury and appears to be involved in repair of many tissues.
Active TGF-,81 is thought to be produced by the action of plasmin [20] on latent TGF-/5. As tissue-type plasminogen activator is produced at sites of vascular injury [21] , active TGF-,5 would be expected to be present at these sites. The TGF-,/ type-II receptor has intrinsic serine/threonine kinase activity [22] and there is evidence that some of its effects are mediated by a decrease in cellular cyclic AMP concentration [23] [24] [25] [26] . However, little is known about the coupling between the receptor kinase activity and the regulation of cyclic AMP. Active TGF-fil can either promote or inhibit cell proliferation in culture depending on the cell type and the conditions. TGF-,/1 is reported to reduce the rate of proliferation of VSMCs stimulated by serum [27] [28] [29] . In the presence of serum, TGF-,/1 caused hypertrophy of normotensive rat VSMCs in addition to reducing their rate of proliferation. The hypertrophic effect was not dependent on growth arrest in the G1-or G2-phases of the cell cycle, or withdrawal of the cells from the cell cycle [27] . In 
MATERIALS AND METHODS Cell culture and counting
The aortae were removed from 12-17-week-old Wistar rats killed by CO2 asphyxiation. VSMCs from the tunica media were dispersed as previously described [38, 40] . Hanks' balanced-salts solution (ICN/Flow) supplemented with 10% (v/v) fetal-calf serum (FCS; ICN/Flow) was used throughout the preparation. The cells (4 x 105/ml) were suspended in medium M 199 (ICN/Flow) supplemented with 12.5 mM sodium bicarbonate, 2 mM glutamine and penicillin (100 units/ml), and plated on to sterile culture dishes (ICN/Flow) at 8.3 x 104 cells/cm2. Cells cultured in the absence of serum were prepared as above except: (1) aortae were removed from 7-9-week-old Wistar rats; (2) serum-free Hanks' balanced-salt solution was used during the preparation so that the cells never came into contact with serum; and (3) the culture dishes were coated (5 'ag/cm2) with bovine plasma fibronectin (Sigma Chemical Co.) in sterile phosphatebuffered saline (137 mM NaCl, 2.7 mM KCI, 8.1 mM Na2HPO4, 0.9 mM CaCl 0.5 mM MgCl2, 1.5 mM KHPO49 pH 7.4) for 45 min, then aspirated. TGF-,f1 purified from pig platelets (Peninsula Labs) was dissolved in 5 mM HCI to give a 5 ,tg/ml stock which was diluted in 25 mM Tris/HCl, pH 7.4, containing 0.2 % BSA and filtered through a 0.22 ,um pore diam. filter to give a 1 ,tg/ml stock. The cells were incubated in 5 % CO2 in air (pH 7.2) at 37 'C; the start of this incubation was defined as 0 h in all time-course experiments and the medium was replaced every 48 h. At 48 h more than 99 % of the cells stained positively for SM-MHC isoforms using an antiserum raised to chicken gizzard smooth muscle myosin (aChGM) as described [41] . Subcultured Where entry into DNA synthesis was assayed by [3H]thymidine incorporation during successive pulses in replicate sets of cells under different conditions (e.g. control cells and cells in the presence ofheparin), the delay in entry into S phase was calculated from the formula:
x T}/(n- 1) where D is the delay in h, n is the total number of successive
[3H]thymidine pulses of equal duration, C, is the counts (c.p.m.) incorporated in the control cells during pulse n = x, Hx is the counts incorporated in the test cells during pulse x, C,.l is the counts incorporated in the control cells during pulse x -1, and T is the duration in h of each pulse. If DNA synthesis is inhibited in the test cells but not delayed, the formula will give a delay of 0 h. If the DNA synthesis time course is broadened (because the cell population is less synchronous) the formula will give a delay of 0 h. If DNA synthesis is delayed and inhibited the formula will give the same delay value as if DNA synthesis is delayed but not inhibited. Comparative estimates of the time taken for cell populations to pass through S phase are obtained from the width (in h) of the pulsed [3H]thymidine incorporation peak at halfpeak height.
Analysis of myosin heavy chain (MHC) isoforms Samples of 4 x 105 cells were prepared for MHC isoform analysis as described for cell counting, centrifuged (900 g; 4 min) and lysed in gel sample buffer [42] after removing the supernatant. The samples were analysed by SDS/PAGE and Western blotting in DMEM plus 10 % (v/v) FCS before performing the as described previously [38] using aChGM [43] to detect SMEffect of transforming growth factor , on cell proliferation 229 MHC and a peroxidase-linked second antibody. Labelling was visualized with diaminobenzidine and H202 in the presence of nickel ions.
Determination of cyclic AMP level
The medium was aspirated and the cells washed three times in ice-cold PBS. The cells were lysed in 6 % (w/v) perchloric acid and the lysate neutralized with 1 M KOH/2 M K2C03. Protein and solid KC104 were precipitated (14000g; 4min) and the supernatant lyophilized and stored at -80 'C. The cyclic AMP content of the lyophilized cell lysate was determined using a cyclic AMP determination kit (Amersham International). Cyclic AMP levels were determined in duplicate for each of six sample dishes at each time point. Values are plotted as means + S.E.M. 10 ng/ml TGF-flI (Figure 2d ). , Figure 4a ), and started to fall by 36 h, when the cells were beginning to re-enter the G1 phase of the cell cycle. In the presence of TGF-3l (10 ng/ml) the increase in cyclic AMP concentration was delayed by approx. 24 h (Figure 4b) The results indicate that cyclic AMP can induce the cells to divide before division occurs in control cells. However, a higher concentration of forskolin was required to achieve premature division than that required to reverse the effect of TGF-,/1 on G2.
RESULTS

Effects
E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E
To test whether the effect of forskolin was due to the increase in cyclic AMP concentration it induces, various membranepermanent analogues of cyclic AMP were tested for their ability to increase the rate of proliferation of subcultured VSMCs, of which 8-(4-chlorophenylthio)-cyclic AMP was the most effective (results not shown). The effect of various concentrations of 8-(4-chlorophenylthio)-cyclic AMP added to the cells 24 h after stimulation by 100% (v/v) FCS was similar to the effect of forskolin in advancing the entry of the cells into mitosis ( Figure  6b) .
The rapid entry of the cells into M phase immediately after S phase was complete, in response to forskolin, raised the question of whether any protein synthesis was required in G2 for the cells to divide. When cycloheximide (35 #uM) was added together with forskolin (5 #M) to cells late in S phase at 24 h, there was little effect on the rate at which the cells subsequently divided ( Figure  6c ). However, if cycloheximide was added before S phase, at 15 h after stimulation with 10 % (v/v) FCS (see Figure 2a) , there was no subsequent division of the cells. This is consistent with evidence that entry into S phase is dependent on protein synthesis until late in G1.
Effects of TGF-fll on stimulation by PDGF and EGF The effect of TGF-fll on the entry into S phase of quiescent, subcultured VSMCs stimulated by PDGF or EGF in the absence of serum was determined. The time course of entry into S phase, assayed by incorporation of [3H]thymidine during 6 h pulses, in response to 100 ng/ml EGF or 100 ng/ml PDGF-BB was similar to the time course in response to 10 % (v/v) FCS (Figures 7a and   7b ). Both EGF and PDGF-BB stimulated much less DNA synthesis than 100% (v/v) FCS and a lower proportion of the cells entered S phase, as assayed by bromodeoxyuridine incorporation. At 36 h, 94 + 20 (n = 3) of cells had entered S phase in response to 10 % (v/v) FCS, 36 + 3 % (n = 3) in response to 100 ng/ml EGF and 54 + 3 % (n = 3) in response to 100 ng/ml PDGF-BB. TGF-,81 ( The biochemical events which are necessary for entry into mitosis are only partially defined in terms of the activation of complexes of cdk(s) with cyclins [48] . Entry into mitosis is not advanced by inhibitors of phosphodiesterases, either in the presence or absence of TGF-/ll, suggesting that activation of adenylate cyclase, rather than inhibition of phosphodiesterases, is the main mechanism by which the cyclic AMP pulse before mitosis is generated. The observation that increases in cyclic AMP induced by forskolin added late in S phase will drive the cells into M phase without requiring further protein synthesis was surprising. The results suggest that the appropriate concentrations of cyclins and cdk(s) for mitosis are already present in the cells at, or very soon after, the end of S phase and that the phosphorylation cascade required for entry into mitosis can be triggered by cyclic AMP-dependent protein kinases. It is unlikely, although not inconceivable, that protein kinase A acts downstream of cdkl, as activation of cdkl is thought to be the key step in entry into M phase and mitosis can be induced by mimicking the cyclic AMP pulse which occurs before mitosis. However, the results provide no indication of the separation in the phosphorylation cascade between the activation of cyclic AMP-dependent protein kinase(s) and the activation of the cdkl complex on entry into mitosis. Phosphorylation studies in vitro and in vivo will be required to analyse the coupling in this pathway. 
